Trend tests for GLP-1 (p = 0.05) and AC3174 (p < 0.05) showed marginally significant dose responses.
← all excerpts
Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
1
—
—